COMMUNIQUÉS West-GlobeNewswire

TAP Sleep Care® Combination Therapy Delivers 95% AHI Reduction in Severe CPAP-Resistant OSA
11/08/2026
Dr. Martin A. Denbar’s clinical case series documents interfaced therapy using TAP-PAP interface with TAP oral appliance DALLAS, Aug. 11, 2026 (GLOBE NEWSWIRE) -- TAP Sleep Care ® today highlighted clinical evidence on [...]
Zus Health Achieves HITRUST r2 Certification, Demonstrating Commitment to Cybersecurity and Information Protection
11/08/2026
BOSTON, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Zus Health , the healthcare data platform that unifies scattered data into an always-on common patient record, today announced that its shared FHIR-native platform residing at [...]
Vor Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update
11/08/2026
Enrollment on track for Phase 3 UPSTREAM MG trial of telitacicept in generalized myasthenia gravis patients with topline results anticipated in 1H27 Enrollment ongoing for Phase 3 UPSTREAM SjD of telitacicept in primary [...]
Microbot Medical® Files 10-Q, Reports Significant Revenue and Customer Growth During the 2026 Second Quarter
11/08/2026
Revenue increased by more than 100% over the prior fiscal quarter, driven by repeat orders, expanded utilization among existing customers, and the acquisition of new customers since the Full Market Release in mid-April [...]
Longeveron Named a Finalist Team and Will Receive a $1,000,000 Milestone 2 Award for the XPRIZE Healthspan Global Competition
11/08/2026
Longeveron selected as a Milestone 2 Awardee based on published clinical trial results which demonstrated laromestrocel increased 6-minute walk distance in patients with Aging-related Frailty MIAMI, Aug. 11, 2026 (GLOBE [...]
Hi*Ball® Energy Powers into the English Football League with Wolverhampton Wanderers Partnership
11/08/2026
English Football League partnership expands Hi*Ball’s UK presence, bringing the clean, zero-sugar sparkling energy brand to one of football’s most passionate fanbases LONDON, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Hi*Ball [...]
Wandercraft Receives FDA Clearance for Eve, the World’s First Self-Balancing Personal Exoskeleton, for Eligible Wheelchair Users Living with Spinal Cord Injuries at Any Level
11/08/2026
Clearance opens a new category of self-balancing robotics for people living with severe mobility disabilities and advances Eve toward commercial launch within established Medicare reimbursement pathway NEW YORK, Aug. 11 [...]
NovelMed Advances Its Ocular Program, Highlighting the Potential of a Single Therapy Across Multiple Retinal Diseases
11/08/2026
--- A Versatile Complement Therapy Across Ocular, Hematologic, Renal, Dermatological, and Inflammatory Disorders. Key Highlights Commercial Precedent for One Molecule, Two Diseases : Biogen’s $5.6 billion acquisition of [...]
Protara Therapeutics Announces Second Quarter 2026 Financial Results and Provides a Business Update
11/08/2026
Expect to complete enrollment of the BCG-Unresponsive registrational cohort of the ADVANCED-2 trial in 4Q 2026 The ADVANCED-3 trial is being redesigned as an exploratory trial to expand into and accelerate data in high- [...]
Noah Medical Announces Galaxy™ II, the Next Dimension in Robotic-Assisted Bronchoscopy
11/08/2026
New functionality gives physicians the freedom to choose the right imaging for every case and a more responsive drive experience without adding capital, complexity, or radiation SAN JOSE, Calif., Aug. 11, 2026 (GLOBE [...]
Gibson Oncology Announces First Patient Completes Initial Treatment Cycle in Phase II Trial of LMP744 for Recurrent Glioblastoma
11/08/2026
Novel Blood-Brain-Barrier-Penetrant Agent Being Evaluated as a Single Therapy in a Trial Conducted by the National Institute of Neurological Disorders and Stroke (NINDS) MIAMI, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Gibson [...]
IMUNON Reports Second Quarter 2026 Financial Results and Provides Business Update
11/08/2026
IMNN-001 is the first frontline treatment candidate to demonstrate the potential for a clinically meaningful overall survival benefit in women newly diagnosed with ovarian cancer Enrollment in the Phase 3 OVATION 3 [...]
YD Bio Launches a Physician-Partnership Initiative in Taiwan with the Announcement of Two Nutraceutical Products in Collaboration with the Taiwan Chronic Disease Healthcare Association and the Future Health Institute
11/08/2026
Two chrono-nutrition formulations — a daytime lipid-soluble “Golden Triangle” formula and a nighttime zinc-plus-calcium formula — were developed in collaboration with the Taiwan CDHA and FHI. The Company intends to [...]
Neuronetics Reports Second Quarter 2026 Financial and Operating Results
11/08/2026
MALVERN, Pa., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient [...]
Arch Biopartners to Expand Phase II Cardiac Surgery-Associated Acute Kidney Injury Trial to the United States
11/08/2026
TORONTO, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Arch Biopartners Inc . (TSX Venture: ARCH and OTCQB: ACHFF) today announced that the Company will expand its ongoing Phase II trial of LSALT peptide targeting cardiac surgery- [...]
Bicara Therapeutics Reports Second Quarter 2026 Progress and Announces Strategic Leadership Transitions Marking Next Era of Execution and Growth
11/08/2026
President & Chief Operating Officer Ryan Cohlhepp, Pharm.D. appointed President & Chief Executive Officer effective January 2027 Claire Mazumdar, Ph.D., MBA to transition to Vice Chair of the Board of Directors [...]
Sagimet Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Updates
11/08/2026
Phase 3 clinical trial of denifanstat in moderate to severe acne patients for the U.S. on track to initiate in second half of 2026 First-in-human Phase 1 clinical trial of FASN inhibitor TVB-3567 ongoing Secured equity [...]
Eikon Therapeutics Announces Dose Selection for TeLuRide-006, an Ongoing Adaptive Phase 2/3 Trial of EIK1001 in Advanced Melanoma
11/08/2026
Selected 0.60 mg/m 2 as the single dose for the TeLuRide-006 study going forward for patients randomized to EIK1001 treatment, in accord with a recommendation of the independent Data Monitoring Committee (DMC) following [...]
Constant Therapy Health Launches Web Platform for Speech, Language, and Cognitive Therapy
11/08/2026
Gives convenient desktop and laptop access to Constant Therapy’s clinically-proven rehabilitation exercise programs LEXINGTON, Mass., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Constant Therapy Health, a leader in AI-powered [...]

Pages